FDA approves generic drug for a rare genetic condition
Digest more
About five months after U.S. Department of Health and Human Services Secretary Robert F. Kennedy Jr. | About five months after U.S. Health Secretary Robert F. Kennedy Jr. touted leucovorin as “an exciting therapy that may benefit large numbers of children who suffer from autism” during a White House press conference,
Corrections and clarifications: Due to an editing error, a previous version of this story mischaracterized the scope of the new FDA approval for leucovorin. In a White House briefing on Sept. 22, Trump, Kennedy, and other officials made several ...
Leucovorin is being reviewed by the FDA for treating cerebral folate deficiency, which causes developmental delays and autism-like features in children. GSK aims to update leucovorin's label for CFD treatment, a condition it has been used off-label for ...